No Data
Truist Financial Maintains Autolus Therapeutics(AUTL.US) With Buy Rating
Autolus Therapeutics Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains Overweight on Autolus Therapeutics, Lowers Price Target to $6
Autolus Therapeutics Analyst Ratings
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Flat for Week
A Quick Look at Today's Ratings for Autolus Therapeutics(AUTL.US), With a Forecast Between $6 to $10
blessings u : Thank you for sharing.
Trytosaveabit OP blessings u : you’re welcome![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)